Answers are grounded in this paper and cite their sources.
Objective Prostate-specific antigen is an androgen-responsive protein used in adult men as a marker of prostate disease; however, its physiological rise during male puberty is poorly described. We evaluated whether serum prostate-specific antigen may serve as a biomarker of pubertal development in healthy boys and established age-specific reference intervals. Design Longitudinal cohort study. Methods The study included 104 healthy boys and 890 serum samples from the Copenhagen Puberty Study II. Serum prostate-specific antigen was measured by commercial immunoassay. Age-specific reference intervals were developed using generalised additive models for location, scale and shape. Total testosterone and sex hormone-binding globulin were measured by immunoassay. Free testosterone was calculated using the Vermeulen equation. Pubertal onset defined as testicular volume > 3 mL. Boys were categorised by genital stage 1 to 5, and group differences were analysed using linear mixed models. Results Prostate-specific antigen increased from 12 years of age, reaching a median concentration of 0.46 µg/L at 16.5 years, with a reference interval of 0.19 - 0.93 µg/L (model-estimated median ±2 SD). It was undetectable in prepubertal boys and at pubertal onset. A significant increase was observed from genital stage 3, indicating that prostate-specific antigen rose after pubertal onset and later than testosterone. Thresholds of > 3.06 nmol/L for total testosterone and > 36 pmol/L for free testosterone predicted detectable prostate-specific antigen. Conclusion Prostate-specific antigen increased with pubertal progression but was not detectable prior to the onset of puberty, suggesting that a threshold of androgen exposure is required for measurable production.
No takes yet. Share an insight, caveat, or question.
Fritzbøger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: